問題詳情

4.有關raloxifene於骨鬆症治療之敘述,下列何者錯誤?

(A)須考量靜脈栓塞病史
(B)依creatinine clearance調整劑量
(C)須注意與cholestyramine之交互作用
(D)須考量肺栓塞之風險

參考答案

答案:B

統計:A:27,B:605,C:122,D:163,E:0

難度:簡單

用户評論

Felicia】評論

※Raloxifene 1.會增加靜脈...

Chi ᵕ̈】評論

(A) 須考量靜脈栓塞病史(B) 依creatinine clearance調整劑量(C) 須注意與cholestyramine之交互作用(D) 須考量肺栓塞之風險 [US Boxed Warning]: Raloxifene may increase the risk for deep vein thrombosis and pulmonary embolism (A)(D); use is contraindicated in patients with history of or current venous thromboembolic disorders          Ref. UptoDateDosing: Kidney Impairment: AdultCrCl ≤50 mL/minute: There are no dosage adjustments (B) provided in the manufacturer’s labeling; use with caution.          Ref. UptoDateConcurrent use of CHOLESTYRAMINE and RALOXIFENE may result in reduc...